Aleafia Health: A New LP with 22 Medical Clinics, 50K Patients and 98,000 kg Production
Ryan Allway December 14th, 2018 Exclusive, News, Top Story The Canadian cannabis market is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of adult-use cannabis nationwide. While many companies are focused on supplying the recreational market, the medical market may... Read more
Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets
Ryan Allway December 5th, 2018 Partnership formed with Dr. Don Garbuz, an award winning orthopaedic surgeon and medical researcher, credited with over 120 peer reviewed publications. The parties will seek to conduct a clinical study with orthopaedic patients, using Canntab’s sustained release tablets. The study aims to show... Read more
FSD Pharma Congratulates Partner Canntab on Launch of Research Partnership with Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D.
– FSD Pharma to work with Canntab to create tablets for the clinical research study at its facility in Cobourg, Ontario, Canada – FSD Pharma Inc. (“FSD Pharma”) (HUGE.CN) (FSDDF) (0K9.F) today congratulated strategic partner Canntab Therapeutics Limited (“Canntab”) (CSE:PILL) (TBF1.F) on the launch of a research partnership with... Read more
Canntab Nears Commercialization with Innovative Cannabis Tablets
Ryan Allway November 28th, 2018 Uncategorized The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. With medical and adult-use legalization across a growing number of countries, there’s an enormous opportunity for... Read more
FSD Pharma’s New CEO is a Top GW Pharma Executive
Ryan Allway November 27th, 2018 News, Top News Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, but the market pales in comparison to the global pharmaceutical industry—which could reach more than $1 trillion by 2020. Cannabis investors shouldn’t ignore the... Read more
Supreme Cannabis Focused on Disciplined Deployment of Capital
Ryan Allway November 21st, 2018 Exclusive, News, Top News The cannabis industry has boomed in recent years supported by the access to inexpensive capital, which has stemmed from a voracious investor appetite for cannabis exposure and the prospects of outsized returns. In turn, many licensed producers have quickly... Read more
BLOCKStrain Brings Security, Scalability, and Transparency to Cannabis Supply Chain
Ryan Allway November 20th, 2018 Uncategorized The cannabis industry is experiencing massive growth, but the infrastructure behind the boom leaves a lot to be desired. Many cultivators are still using spreadsheets to track products across the supply chain, while regulators are struggling to find good ways to track... Read more
Aleafia Health to Launch Global Cannabis Education Platform with D2L
Platform to Provide Cannabis Education Courses TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“Aleafia”) has entered into a global agreement with D2L (Desire2Learn) Corporation (“D2L“), in which Aleafia Health will deploy D2L’s Learning Management System (LMS) Brightspace. Brightspace is a cloud-based... Read more
MedMen Expanding Across the US Legal Cannabis Markets
Ryan Allway November 15th, 2018 Exclusive, News, Top Story The recent elections brought the total number of states allowing some form of legalized cannabis to 33, with Michigan expanding its medical program to full adult use legalization and both Utah and Missouri voting for regulated medical programs. The... Read more
FSD Pharma Adds David Urban to Board Of Directors
Ryan Allway November 14th, 2018 TORONTO – November 14, 2018 – FSD Pharma Inc. (“FSD Pharma” or the “Company”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of David Urban to the Company’s Board of Directors. Mr. Urban is an accomplished business and government relations executive.... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )